Survey of Pharmacist-manned drug information centers in the United States

Rosenberg, Jack M.; Raina, M. K.; Kirschenbaum, Harold L.

doi:10.1093/ajhp/34.11.1201

Cited by 9 publications

(11 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is currently no generally accepted criteria for measuring DIC competency, however, and few attempts have been made to assess the complexity of requests (1,10). Studies have reported that 5%-46% of all drug information questions require judgemental responses (1,5,10). Ad ditionally, one DIC developed criteria to review its clinical services and rated 73% of drug information communicated as sig nificant to highly significant (1).…”

Section: Cost Justificationmentioning

confidence: 99%

“…Centers also have no uniform methodol ogy for assessing impact on physician pre scribing (5). Many drug information pharma cists believe that their services have a positive effect on patient care (40%-85% of DICs) (1,5,10).…”

Section: Cost Justificationmentioning

confidence: 99%

“…Pharmaceutical industry infor mation centers also began at this time and have continued to evolve. Several nation wide surveys (dating from 1974) of phar macist-manned centers have provided com prehensive information concerning DIC staff ing, funding, resources, and services (2)(3)(4)(5)(6)(7)(8)(9)(10). Additionally, industry drug information services have recently been compared with academic/clinical site DICs (11).…”

mentioning

confidence: 99%

See 2 more Smart Citations

Fee-For-Service and Cost Justification Activities of Pharmacist-Manned Drug Information Centers in the United States

Price

Rosenberg

Rumore

1991

Drug Information Journal

Self Cite

View full text Add to dashboard Cite

In the current era of economic constraints, it is becoming increasingly difficult to obtain sufficient funds for drug information services. Many drug information centers (DICs) are becoming less financially secure and so alternative funding sources are becoming essential for maintaining quality services. Additionally, it is becoming more important for centers to provide cost justification data to support their existence. There is a paucity of published data concerning cost effectiveness and fund-gener ating activities of DICs. The purpose of this article is to present an overview of and recommendations for fee-for-service and cost-justification activities of DICs in the United States. DICs offer valuable services that can be enhanced through additional revenue gained from fee-for-services activities. To sell drug information services, centers must provide cost-justification data to current and prospective subscribers. In the cost containment world of the 1990s, DICs must be able to prove that they save money by lowering medical costs. Results indicate the need for cost-justification studies and demonstrate the hazards of less than rigorous study. Cost-effectiveness evidence is likely to emerge as the driving force behind DIC funding in the future.

show abstract

Section: Cost Justificationmentioning

confidence: 99%

Section: Cost Justificationmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Fee-For-Service and Cost Justification Activities of Pharmacist-Manned Drug Information Centers in the United States

Price

Rosenberg

Rumore

1991

Drug Information Journal

Self Cite

View full text Add to dashboard Cite

show abstract

“…Cramer recently advocated that differences in professional services (ie, drug information) provided by drug companies be considered in a hos pital's drug purchasing and formulary policies (23). Surveys conducted have helped to characterize the number, loca tion, and scope of DIC services (24)(25)(26)(27)(28)(29).…”

mentioning

confidence: 99%

“…One of the authors (JMR) has published directories of pharmacist-operated DICs since 1977 and provided information con cerning the status, availability, and scope of their services (25,26,28,29). Dombrowski conducted a national audit of DICs for information on sources of fund ing, staffing, information resources, com puterization, workload, and scope of ser vices (27).…”

mentioning

confidence: 99%

Comparison of Drug Information Practice in Hospitals and Industry

Rumore

Rosenberg

1989

Drug Information Journal

Self Cite

View full text Add to dashboard Cite

To assess the type of information requested of a pharmaceutical manufacturer, re quests received over a 12 month period in the Professional Services Department of Sterling Drug Inc were reviewed. To compare drug information services of Sterling Drug with those of pharmacist-operated drug information centers (DICs), requests were classified as to the nature of the question, category of requestor, and patient specificity. Questions regarding dosage or administration, drug identification, and adverse drug events were common in both DICs and industry. At Sterling Drug Inc the largest number of requests were for literature reprints or physician drug samples and dosage or administration. This contrasts with hospital-based DICs, where the largest number of requests pertained to therapeutic use and drug efficacy or adverse drug events. At Sterling and DICs few questions pertained to pharmacology, toxicol ogy or poisoning, and pharmacokinetics. Physicians comprised the largest group of requestors in DICs. Professional and support staffing of DIC and industry drug information practice are compared. Staffing by PharmDs and RPhs was practically identical for drug information services regardless of whether the practice site was industry or DIC.

show abstract